Close Menu

NEW YORK – German infectious disease diagnostics startup Noscendo said on Thursday that it has raised an undisclosed amount of funding in a Series A financing round.

Participants in the round included existing investors Wieland Capital and High-Tech Gründerfonds and new investors Earlybird, Paua Ventures, and JIH Family Office.

Noscendo plans to use the funding to expand its business, hiring a CSO and a chief operating officer and launching its Disqver bioinformatics platform for the detection of cell-free pathogen DNA in blood in Europe.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

European regulators have begun a rolling review of Russia's Sputnik V SARS-CoV-2 vaccine, Reuters reports.

Science reports that Science Foundation Ireland is seeking annual budget increases.

According to the Financial Times, a UK university group is pushing Elsevier to lower its journal fees.

In Nature this week: satellite tracking and genome sequencing combination used to examine migration patterns of peregrine falcons, and more.